Cargando…
Biology of premature ageing in survivors of cancer
Over 30 million cancer survivors exist worldwide. Survivors have an earlier onset and higher incidence of chronic comorbidities, including endocrinopathies, cardiac dysfunction, osteoporosis, pulmonary fibrosis, secondary cancers and frailty than the general population; however, the fundamental basi...
Autores principales: | Cupit-Link, Margaret C, Kirkland, James L, Ness, Kirsten K, Armstrong, Gregory T, Tchkonia, Tamar, LeBrasseur, Nathan K, Armenian, Saro H, Ruddy, Kathryn J, Hashmi, Shahrukh K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757468/ https://www.ncbi.nlm.nih.gov/pubmed/29326844 http://dx.doi.org/10.1136/esmoopen-2017-000250 |
Ejemplares similares
-
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
por: Justice, Jamie N., et al.
Publicado: (2019) -
CELLULAR SENESCENCE AS A THERAPEUTIC TARGET FOR GEROSCIENCE-GUIDED CLINICAL TRIALS
por: Justice, Jamie N, et al.
Publicado: (2019) -
Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity
por: Palmer, Allyson K., et al.
Publicado: (2015) -
Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood Cancer
por: Armenian, Saro H., et al.
Publicado: (2012) -
Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability
por: Nambiar, Anoop, et al.
Publicado: (2023)